Trials Starting With "S"

S100A1

      -Absence of S100A1 in mice is associated with a hypertensive phenotype dependent on both gender and endothelial function by Dr. Jean-Francois Desjardins (AHA 2007)

 

Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients with Acute Coronary Syndromes and Reduced Renal Function:

      -Overview by Dr. Chiara Melloni

 

SAFER: SVG Angioplasty Free of Emboli Randomized

      -Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention by Dr. Donald S. Baim (TCT 2000)

SAGE: Study Assessing Goals In The Elderly

      -Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE) by Dr. Prakash Deedwania

SAPPHIRE: Stenting And Angioplasty With Protection In Patients At High Risk For Endarterectomy

      -Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy by Dr. Jay Yadav (AHA 2002)

 

SATURN: Comparison of the Progression of Coronary Atherosclerosis for Two High-efficacy Statin Regimens with Different HDL Effects

      -Trial Overview by Dr. Stephen Nicholls (AHA 2011)

 

SCAAR: Non-randomized Comparison from SCAAR of Eptifibatide vs Abciximab in Primary PCI for STEMI

      -Results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) by Dr. Axel Akerblom

SCANDSTENT: Stenting Of Coronary Arteries In Non Stress/Benestent Disease Trial

      -Stenting of Coronary Arteries in Non Stress/Benestent Disease by Dr. Henning Kelbaek (ACC 2005)

SCD-HeFT: Sudden Cardiac Death in Heart Failure Trial

      -All-cause mortality at 5 years by Dr. Gust H. Bardy (ACC 2004)

SEA-CORP BC: SEAside and CORpal Bifurcation trials Cooperative study

      -Trial Overview Dr. Francesco Burzotta (TCT 2012)

SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine

      -Trial Overview by Dr. Rory Collins and Dr. Jane Armitage

SEISMIC: The Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) using an Injection Catheter Trial

      -The Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) using an Injection Catheter Trial by Dr. Patrick W. Serruys (ACC 2008)

SEPIA-ACS1-TIMI 42: The Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) using an Injection Catheter Trial - Thrombolysis In Myocardial Infarction 42

      -Safety and Efficacy of Otamixaban for the Treatment of NSTE-ACS by Dr. Marc S. Sabatine

SESAMI: Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction

      -Randomized trial of Sirolimus Stent vs Bare Stent in Acute Myocardial Infarction by Dr. Maurizio Menichelli

      -Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial by Dr. Maurizio Menichelli (EuroPCR 2006)

 

SHARP: Study of Heart and Renal Protection

      -Trial Results by Dr. Colin Baigent and Dr. Martin Landray

SIAM III: Southwest German Interventional Study In Acute Myocardial Infarction

      -SIAM III Trial Results

Side Branch Stenting Using Sirolimus-Eluting Stents in Bifurcation Lesions Trial

      -Trial Overivew by Dr. Terje K. Steigen (ACC 2006)

Simvastatin Increases HDL-C and Apolipoprotein A-1 Levels Significantly More Than Atorvastatin

      -Simvastatin Increases HDL-C and Apolipoprotein A-1 Levels Significantly More Than Atorvastatin by Dr. John P. Kastelein

SIRIUS: Sirolimus-Eluting Stent In Coronary Lesions

      -SIRIUS Trial Results

      -SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions (TCT 2002)

      -Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses by Dr. David J. Cohen (ACC 2003)

SIRTAX: Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization

      -Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization by Dr. Stephan Windecker (ACC 2005)

SIRTAX-LATE: Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization

      -5-Year Clinical and Angiographic Follow-up by Dr. Lorenz Räber, et al. (ACC 2009)

 

SMART-AV DELAY: Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT)

      -Trial Overview by Dr. Kenneth Ellenbogen (AHA 2010)

SMASH-VT: Substrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia

      -Trial Overview by Dr. Vivek Reddy (HRS 2006)

SOLVD: Studies of Left Ventricular Dysfunction

      -SOLVD (Studies of Left Ventricular Dysfunction)

 

SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

      -SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease by Dr. Jens Fensted Lassen (TCT 2008)

      -Trial Overview by Dr. Michael Maeng (ACC 2010)

 

SOURCE TAVI Cohort 2: 2,300 Lower Risk and "Valve-in-Valve" Patients Undergoing Transcatheter Aortic Valve Implantation

      -A Prospective Observational Study of More Than 2,300 Lower Risk and "Valve-in-Valve" Patients Undergoing Transcatheter Aortic Valve Implantation by Dr. Martyn R. Thomas (TCT 2010)

 

SPEED: Strategies for Patency Enhancement in the Emergency Department

      -SPEED: Strategies for Patency Enhancement in the Emergency Department. GUSTO-IV Pilot Trial (ACC 1999)

SPECT Pilot Study Multi-center Assessment of the Utilization of SPECT Myocardial Perfusion Imaging Using the ACCF Appropriateness Criteria

      -Late Breaking Clinical Trial Presentation at ACC 2009 by Dr. Robert C. Hendel

SPIDER: Saphenous Vein Graft Protection In a Distal Embolic Protection Randomized Trial

      -Saphenous Vein Graft Protection In a Distal Embolic Protection Randomized Trail by Dr. Simon R. Dixon (TCT 2005)

SPIRIT III: A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

      -A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease 2-Year Clinical Follow-Up by Dr. Gregg W. Stone

      -SPIRIT III: A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease 1-Year Follow-Up and Subgroup Analysis by Dr. Gregg W. Stone (TCT 2007)

      -ACUITY: Long Term Results and SPIRIT III: Trial designed to compare Abbott's XIENCE V Everolimus Eluting Coronary Stent System with Boston Scientific's TAXUS Paclitaxel-Eluting Coronary Stent System by Dr. Gregg W. Stone

SPIRIT IV: A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

      -One Year Clinical Results by Dr. Gregg W. Stone (TCT 2009)

SPORTIF III: Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Nonvalvular Atrial Fibrillation

      -Trial Overview Presented at ACC 2003

SPORTIF V: Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Nonvalvular Atrial Fibrillation

      -Trial Overview by Dr. Jonathan L. Halperin (AHA 2003)

 

STACCATO: A Prospective, Randomized Trial of Transapical Transcatheter Aortic Valve Replacement vs. Surgical Aortic Valve Replacement in Low-Surgical-Risk Elderly Patients with Aortic Stenosis

      -Trial Overview by Dr. Leif Thuesen (TCT 2011)

 

State of the Art Review: Carotid Stenting, Patient Selection, and Clinical Trial Results

      -Trial Overview by Dr. William A. Gray

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

      -Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis by Dr. Stephen J. Nicholls

STATINS PRE-PCI: A Prospective, Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina

      -Trial Overview by Dr. Josef Veselka (TCT 2009)

STEEPLE: Safety and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: An International Randomized Evaluation

      -Trial Overview by Dr. Gilles Montalescot (ESC 2005)

      -One-Year Follow-Up by Dr. Gilles Montalescot

STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients

      -STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients by Dr. Bruce Brodie (TCT 2009)

 

STEMI-RADIAL: Radial vs. Femoral Access in Patients with ST-Segment Elevation Myocardial Infarction

      -Trial Overview by Dr. Ivo Bernat (TCT 2012)

 

Stent for Life Initiative: Improving the Delivery and Patient Access to Life Saving Indications of PCI to Reduce Mortality and Morbidity of Patients Suffering from Acute Coronary Syndromes

      -Overview by Dr. Mohamed Sobhy (C3 Complex Intervention Meeting 2011)

STICH: Surgical Treatment of Ischemic Heart Failure

      -Quality of Life and Economic Outcomes with Surgical Ventricular Reconstruction in Symptomatic Heart Failure by Dr. Daniel B. Mark (ACC 2009)

    -Medical Therapy with or without Coronary Artery Bypass Graft Surgery in Patients with Ischemic Cardiomyopathy: Results of the Surgical Treatment of Ischemic Heart Failure Trial by Dr. Eric J. Velazquez (ACC 2011)

     -Influence of Myocardial Viability on Outcome of Patients with Coronary Artery Disease and Left Ventricular Dysfunction Undergoing Medical Therapy with and without Surgical Revascularization by Dr. Daniel B. Mark (ACC 2011)

STRADIVARIUS: Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study

      -Effect of Rimonabant on Progression of Atherosclerosis in Patients with Abdomiinal Obesity and Coronary Artery Disease by Dr. Steven E. Nissen

STRATEGY: Single High-Dose Bolus Tirofiban And Sirolimus-Eluting Stent Vs. Abciximab And Bare-Metal Stent In Myocardial Infarction

      -Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction by Dr. Marco Valgimigli

STRATUS-US: Smoking Cessation In Smokers Motivated To Quit

      -Smoking Cessation in Smokers Motivated to Quit by Dr. Robert Anthenelli (ACC 2004)

Stress Perfusion Imaging Versus Stress Wall Motion Imaging

      -Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Excercise Echocardiography by Dr. Thomas R. Porter (AHA 2012)

SUNSET Registry

      -Clopidogrel Use and Death/MI After Stent Implantation in a Diabetic Population by Dr. Somjot S. Brar (SCAI 2007)

SURVIVE-W: Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support

      -Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support by Dr. Alexandre Mebazaa (AHA 2005)

STENT Group

      -Late "Catch-Up" in Target Vessel Revascularization with DES vs BMS in SVG Intervention: Two Year Results from the STENT Group by Dr. Bruce R. Brodie (TCT 2009)

SVG WRIST: Washington Radiation for In-Stent restenosis Trial for Saphenous Vein Grafts

      -Intravascular Gamma Radiation for In-Stent Restenosis in Saphenous-Vein Bypass Grafts by Dr. Ron Waksman

SWEDMAF: The SWEDish Multicentre Atrial Fibrillation study

      -Trial Overview by Dr. Carina Blomstrom-Lundqvist (Heart Rhythm Society Meeting 2006)

SWISS-AMI: Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction

      -Four Months Results by Dr. Daniel Suerder (AHA 2012)

SYNERGY: Superior Yield of the New strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors

      -30-day Results by Dr. Kenneth W. Mahaffey and Dr. James J. Ferguson

SYNERGY PCI: A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention

      -SYNERGY PCI: A Subset analysis of the SYNERGY trial

SYNTAX: Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery

      -Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial by Dr. David J. Cohen (ACC 2009)

      -The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surger: The SYNTAX Study Primary Endpoint Results at One Year in the Randomized Cohort by Dr. Patrick W. Serruys and Dr. Friedrich W. Mohr

      -The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surger: The SYNTAX Study One Year Results of the PCI and CABG Registries by Dr. Patrick W. Serruys and Dr. Friedrich W. Mohr

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs test

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster